本页面由Tiger Trade Technology Pte. Ltd.提供服务

Maze Therapeutics

27.70
+0.59002.18%
盘后:27.700.00000.00%19:43 EDT
成交量:143.79万
成交额:4,037.28万
市值:15.30亿
市盈率:-11.00
高:29.32
开:27.11
低:26.66
收:27.11
52周最高:53.65
52周最低:21.95
股本:5,524.87万
流通股本:3,725.03万
量比:1.96
换手率:3.86%
股息:- -
股息率:- -
每股收益(TTM):-2.5172
每股收益(LYR):-3.0510
净资产收益率:-37.35%
总资产收益率:-21.79%
市净率:3.38
市盈率(LYR):-9.08

数据加载中...

2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report